Maxim Group Downgrades Tekmira Pharma (TKMR) to Hold
Tweet Send to a Friend
Maxim Group downgraded Tekmira Pharma (NASDAQ: TKMR) from Buy to Hold with a price target of $14.00 (from $27.00).Analyst Jason ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE